---

---

entities : Perrigo company    symbols : JNJ   

save search

---

First Approval for Rare Pediatric Cancer; New OTC Opioid Overdose Option
Published: 2024-04-24 (Crawled : 16:00) - biospace.com/
ABT | News | $106.89 -0.65% -0.22% 5.1M |

Health Technology

| 0.0% | O: -1.04% H: 0.0% C: 0.0%
PRGO | $31.23 2.43% 0.0% 960K |

Health Technology

| 0.0% | O: 0.1% H: 0.0% C: 0.0%
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| 0.0% | O: -1.02% H: 0.0% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| 0.0% | O: 0.82% H: 0.0% C: 0.0%
rare first opioid approval for

---

FDA Rejects Abeona’s Gene Therapy, Approves ImmunityBio’s Bladder Cancer Treatment
Published: 2024-04-23 (Crawled : 13:30) - biospace.com/
PRGO | $31.23 2.43% 0.0% 960K |

Health Technology

| 1.43% | O: 0.13% H: 1.89% C: 1.3%
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| 0.89% | O: 0.89% H: 0.0% C: 0.0%
ABT | News | $106.89 -0.65% -0.22% 5.1M |

Health Technology

| 0.49% | O: 0.56% H: 0.41% C: -0.07%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| 1.7% | O: 1.7% H: 0.0% C: 0.0%
fda bladder cancer treatment

---

Genentech’s ALK Inhibitor First Adjuvant Treatment for ALK-Positive, Early NSCLC
Published: 2024-04-19 (Crawled : 15:00) - biospace.com/
PRGO | $31.23 2.43% 0.0% 960K |

Health Technology

| 1.5% | O: -0.4% H: 3.01% C: 2.94%
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| 3.25% | O: 0.83% H: 1.35% C: 1.2%
ABT | News | $106.89 -0.65% -0.22% 5.1M |

Health Technology

| 1.12% | O: -0.75% H: 0.0% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| 3.41% | O: 0.82% H: 0.0% C: 0.0%
first treatment for

---

AstraZeneca Wins Label Expansion for Severe Asthma Drug in Younger Kids
Published: 2024-04-12 (Crawled : 14:30) - biospace.com/
PRGO | $31.23 2.43% 0.0% 960K |

Health Technology

| -2.53% | O: -0.13% H: 0.0% C: -2.94%
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| -0.69% | O: -1.65% H: 0.0% C: 0.0%
ABT | News | $106.89 -0.65% -0.22% 5.1M |

Health Technology

| -3.46% | O: -1.06% H: 0.21% C: -1.05%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| -0.73% | O: -3.02% H: 0.0% C: 0.0%
drug label astrazeneca expansion for kids

---

Busy Weekend Sees Tumor-Agnostic Win for Enhertu, Another Rejection for Supernus
Published: 2024-04-08 (Crawled : 15:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480 |

Health Technology

| 1.68% | O: 2.24% H: 0.0% C: -0.8%
PRGO | $31.23 2.43% 0.0% 960K |

Health Technology

| -2.9% | O: 0.96% H: 1.17% C: 0.16%
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| -1.88% | O: -0.48% H: 0.0% C: 0.0%
ABT | News | $106.89 -0.65% -0.22% 5.1M |

Health Technology

| -3.25% | O: 0.09% H: 0.16% C: -0.7%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| 0.29% | O: 0.84% H: 0.0% C: 0.0%
for

---

FDA Greenlights New Antibiotic for SAB, Pneumonia
Published: 2024-04-05 (Crawled : 13:30) - biospace.com/
SNYNF | News | $94.25 -2.18% 480 |

Health Technology

| -1.93% | O: -1.77% H: 0.0% C: -1.81%
PRGO | $31.23 2.43% 0.0% 960K |

Health Technology

| -3.05% | O: -0.22% H: 0.8% C: 0.06%
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| -3.69% | O: -1.84% H: 0.0% C: 0.0%
ABT | News | $106.89 -0.65% -0.22% 5.1M |

Health Technology

| -2.29% | O: -0.37% H: 1.42% C: 1.37%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| -3.16% | O: -3.44% H: 0.0% C: 0.0%
fda for

---

FDA Approves Vanda Schizophrenia Drug for Bipolar I Disorder
Published: 2024-04-03 (Crawled : 13:30) - biospace.com/
PRGO | $31.23 2.43% 0.0% 960K |

Health Technology

| -2.65% | O: -0.29% H: 1.34% C: -0.64%
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| -5.12% | O: 0.02% H: 0.0% C: 0.0%
ABT | News | $106.89 -0.65% -0.22% 5.1M |

Health Technology

| -3.95% | O: 0.11% H: 0.37% C: -0.77%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| -1.34% | O: 0.69% H: 0.0% C: 0.0%
fda drug schizophrenia

---

AstraZeneca Kicks Off April With New PNH Approval
Published: 2024-04-02 (Crawled : 13:30) - biospace.com/
PRGO | $31.23 2.43% 0.0% 960K |

Health Technology

| -5.05% | O: -1.09% H: 0.13% C: -1.39%
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| -5.15% | O: -0.77% H: 0.8% C: 0.74%
ABT | News | $106.89 -0.65% -0.22% 5.1M |

Health Technology

| -4.01% | O: -0.18% H: 0.47% C: 0.12%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| -3.5% | O: -1.14% H: 0.02% C: -1.06%
approval astrazeneca

---

FDA Approves Treatments for Anemia in Chronic Kidney Disease, Hepatitis
Published: 2024-03-29 (Crawled : 19:00) - biospace.com/
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| Email alert Add to watchlist
ABT | News | $106.89 -0.65% -0.22% 5.1M |

Health Technology

| Email alert Add to watchlist
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| Email alert Add to watchlist
PRGO | $31.23 2.43% 0.0% 960K |

Health Technology

| Email alert Add to watchlist
SNYNF | News | $94.25 -2.18% 480 |

Health Technology

| Email alert Add to watchlist
fda hepatitis kidney anemia

---

FDA Approves New Treatments for Two Rare Diseases
Published: 2024-03-27 (Crawled : 13:30) - biospace.com/
SNYNF | News | $94.25 -2.18% 480 |

Health Technology

| -5.71% | O: -0.26% H: 0.0% C: 0.0%
PRGO | $31.23 2.43% 0.0% 960K |

Health Technology

| -1.01% | O: 0.84% H: 1.48% C: 1.29%
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| -3.84% | O: 0.3% H: 0.0% C: 0.0%
ABT | News | $106.89 -0.65% -0.22% 5.1M |

Health Technology

| -2.58% | O: 1.48% H: 0.0% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| -4.35% | O: 1.06% H: 0.0% C: 0.0%
fda rare

---

Regeneron Hit With Two CRLs, J&J’s PAH Treatment Approved
Published: 2024-03-25 (Crawled : 15:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480 |

Health Technology

| 0.56% | O: -100.0% H: NaN% C: Infinity%
PRGO | $31.23 2.43% 0.0% 960K |

Health Technology

| -2.65% | O: 0.35% H: 0.35% C: -1.34%
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| -3.79% | O: 0.04% H: 0.0% C: 0.0%
ABT | News | $106.89 -0.65% -0.22% 5.1M |

Health Technology

| -2.7% | O: -0.07% H: 0.0% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| -2.1% | O: 0.42% H: 0.0% C: 0.0%
approved treatment

---

Italfarmaco’s Duvyzat, Idorsia’s Tryvio Earn FDA Nods for DMD, Hypertension
Published: 2024-03-22 (Crawled : 15:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480 |

Health Technology

| -1.02% | O: -1.58% H: 0.0% C: 0.0%
PRGO | $31.23 2.43% 0.0% 960K |

Health Technology

| -3.45% | O: 0.35% H: 0.99% C: -1.17%
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| -3.78% | O: 0.02% H: 0.0% C: 0.0%
ABT | News | $106.89 -0.65% -0.22% 5.1M |

Health Technology

| -3.94% | O: -0.43% H: 0.41% C: -0.85%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| -0.84% | O: 1.47% H: 0.23% C: -0.19%
fda hypertension

---

Italfarmaco’s Duvyzat, Idorsia’s Tryvio Earn FDA Nod for DMD, Hypertension
Published: 2024-03-22 (Crawled : 14:30) - biospace.com/
SNYNF | News | $94.25 -2.18% 480 |

Health Technology

| -1.02% | O: -1.58% H: 0.0% C: 0.0%
PRGO | $31.23 2.43% 0.0% 960K |

Health Technology

| -3.45% | O: 0.35% H: 0.99% C: -1.17%
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| -3.78% | O: 0.02% H: 0.0% C: 0.0%
ABT | News | $106.89 -0.65% -0.22% 5.1M |

Health Technology

| -3.94% | O: -0.43% H: 0.41% C: -0.85%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| -0.84% | O: 1.47% H: 0.23% C: -0.19%
fda hypertension

---

FDA Approves Takeda’s Iclusig for Type of Leukemia, Idorsia’s Hypertension Drug
Published: 2024-03-21 (Crawled : 13:30) - biospace.com/
SNYNF | News | $94.25 -2.18% 480 |

Health Technology

| -0.65% | O: 0.14% H: 0.24% C: 0.24%
PRGO | $31.23 2.43% 0.0% 960K |

Health Technology

| -2.59% | O: 0.0% H: 1.6% C: 0.89%
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| -3.81% | O: -0.03% H: 0.0% C: 0.0%
ABT | News | $106.89 -0.65% -0.22% 5.1M |

Health Technology

| -4.47% | O: -0.56% H: 0.0% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| -0.55% | O: 0.3% H: 0.0% C: 0.0%
fda drug iclusig hypertension

---

FDA Approves First Gene Therapy for Rare Pediatric Disease
Published: 2024-03-18 (Crawled : 23:00) - biospace.com/
PRGO | $31.23 2.43% 0.0% 960K |

Health Technology

| 0.4% | O: 0.33% H: 0.13% C: -1.51%
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| -5.43% | O: 0.2% H: 0.08% C: -1.14%
ABT | News | $106.89 -0.65% -0.22% 5.1M |

Health Technology

| -5.13% | O: 1.71% H: 0.36% C: -2.52%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| -2.81% | O: -0.81% H: 0.0% C: 0.0%
fda rare first disease therapy

---

Madrigal’s Rezdiffra, BMS’s Breyanzi Lead Week of Landmark FDA Approvals
Published: 2024-03-15 (Crawled : 15:00) - biospace.com/
PRGO | $31.23 2.43% 0.0% 960K |

Health Technology

| -1.23% | O: -0.62% H: 0.59% C: -1.01%
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| -6.92% | O: -1.58% H: 0.0% C: 0.0%
ABT | News | $106.89 -0.65% -0.22% 5.1M |

Health Technology

| -10.38% | O: -5.53% H: 0.0% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| -2.83% | O: -0.02% H: 0.0% C: 0.0%
fda breyanzi week

---

FDA Decisions: Wegovy Approved for CV Indication; Viatris and Mapi’s MS Drug ...
Published: 2024-03-11 (Crawled : 17:00) - biospace.com/
PRGO | $31.23 2.43% 0.0% 960K |

Health Technology

| 0.79% | O: 0.0% H: 2.38% C: 1.12%
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| -5.84% | O: 0.43% H: 0.0% C: 0.0%
ABT | News | $106.89 -0.65% -0.22% 5.1M |

Health Technology

| -10.93% | O: 0.26% H: 0.0% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| -2.08% | O: 0.57% H: 0.0% C: 0.0%
fda drug wegovy approved

---

FDA Decisions: Wegovy Approved for CV Indication; Viatris and Mapi’s MS Drug Rejected
Published: 2024-03-11 (Crawled : 14:30) - biospace.com/
PRGO | $31.23 2.43% 0.0% 960K |

Health Technology

| 0.79% | O: 0.0% H: 2.38% C: 1.12%
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| -5.84% | O: 0.43% H: 0.0% C: 0.0%
ABT | News | $106.89 -0.65% -0.22% 5.1M |

Health Technology

| -10.93% | O: 0.26% H: 0.0% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| -2.08% | O: 0.57% H: 0.0% C: 0.0%
fda drug wegovy approved

---

FDA Decisions: BeiGene Secures Record Fifth Oncology Approval for Brukinsa
Published: 2024-03-08 (Crawled : 18:00) - biospace.com/
PRGO | $31.23 2.43% 0.0% 960K |

Health Technology

| 2.69% | O: 0.98% H: 3.17% C: 0.9%
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| -6.48% | O: -0.68% H: 0.0% C: 0.0%
ABT | News | $106.89 -0.65% -0.22% 5.1M |

Health Technology

| -10.41% | O: 0.58% H: 0.0% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| -2.16% | O: -0.08% H: 0.0% C: 0.0%
fda brukinsa approval

---

FDA Decisions: BeiGene Secures Record Fifth Oncology Approval for Brukinsa; Opdivo Approved for B...
Published: 2024-03-08 (Crawled : 17:00) - biospace.com/
PRGO | $31.23 2.43% 0.0% 960K |

Health Technology

| 2.69% | O: 0.98% H: 3.17% C: 0.9%
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| -6.48% | O: -0.68% H: 0.0% C: 0.0%
ABT | News | $106.89 -0.65% -0.22% 5.1M |

Health Technology

| -10.41% | O: 0.58% H: 0.0% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| -2.16% | O: -0.08% H: 0.0% C: 0.0%
fda opdivo approved approval

---

Gainers vs Losers

62%

38%

Top 10 Gainers

CSSE 4 | $0.4323 183.85% 64.77% 220M |

Consumer Services

BOF | $1.99 70.09% 41.21% 110M |

ILAG | $0.51 6.03% 40.62% 1.7M |

LICN | $0.941 68.04% 40.49% 15M |

AMST | $3.31 65.5% 39.58% 70M |

Technology Services

MTC | $3.615 61.38% 38.04% 9.3M |

Technology Services

WIMI | $1.15 58.53% 36.92% 19M |

Technology Services

AIH | $0.45 12.5% 30.92% 320K |

Health Services

MULN | News | $3.78 38.46% 27.78% 13M |

Information

RILY | $29.86 37.48% 27.26% 12M |

Finance

---

Your saved searches

---